Epoprostenol (prostacyclin) and severe arterial disease: a double-blind trial

J. J. F. Belch; B. McArdle; J. G. Pollock; C. D. Forbes; A. Mckay; P. Leiberman; G. D. O. Lowe; C. R. M. Prentice

doi:10.1016/S0140-6736(83)91625-2

Epoprostenol (prostacyclin) and severe arterial disease: a double-blind trial

J. J. F. Belch, B. McArdle, J. G. Pollock, C. D. Forbes, A. Mckay, P. Leiberman, G. D. O. Lowe, C. R. M. Prentice

Research output: Contribution to journal › Article › peer-review

107 Citations (Scopus)

Abstract

A 96 h infusion of epoprostenol (prostacyclin) or placebo was given as a treatment for rest pain to 28 patients with severe peripheral arterial disease. 24 h after the end of the infusion patients given epoprostenol had significantly less pain and took fewer analgesics tablets than did the controls. In some patients the epoprostenol effect lasted for over 1 month.

Original language	English
Pages (from-to)	315-317
Number of pages	3
Journal	Lancet
Volume	321
Issue number	8320
DOIs	https://doi.org/10.1016/S0140-6736(83)91625-2
Publication status	Published - 1983

Access to Document

10.1016/S0140-6736(83)91625-2

Cite this

@article{72dc7240b7b94c60b730afcf56037553,

title = "Epoprostenol (prostacyclin) and severe arterial disease: a double-blind trial",

abstract = "A 96 h infusion of epoprostenol (prostacyclin) or placebo was given as a treatment for rest pain to 28 patients with severe peripheral arterial disease. 24 h after the end of the infusion patients given epoprostenol had significantly less pain and took fewer analgesics tablets than did the controls. In some patients the epoprostenol effect lasted for over 1 month.",

author = "Belch, {J. J. F.} and B. McArdle and Pollock, {J. G.} and Forbes, {C. D.} and A. Mckay and P. Leiberman and Lowe, {G. D. O.} and Prentice, {C. R. M.}",

note = "Originally published as Volume 1, Issue 8320",

year = "1983",

doi = "10.1016/S0140-6736(83)91625-2",

language = "English",

volume = "321",

pages = "315--317",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "8320",

}

TY - JOUR

T1 - Epoprostenol (prostacyclin) and severe arterial disease

T2 - a double-blind trial

AU - Belch, J. J. F.

AU - McArdle, B.

AU - Pollock, J. G.

AU - Forbes, C. D.

AU - Mckay, A.

AU - Leiberman, P.

AU - Lowe, G. D. O.

AU - Prentice, C. R. M.

N1 - Originally published as Volume 1, Issue 8320

PY - 1983

Y1 - 1983

N2 - A 96 h infusion of epoprostenol (prostacyclin) or placebo was given as a treatment for rest pain to 28 patients with severe peripheral arterial disease. 24 h after the end of the infusion patients given epoprostenol had significantly less pain and took fewer analgesics tablets than did the controls. In some patients the epoprostenol effect lasted for over 1 month.

AB - A 96 h infusion of epoprostenol (prostacyclin) or placebo was given as a treatment for rest pain to 28 patients with severe peripheral arterial disease. 24 h after the end of the infusion patients given epoprostenol had significantly less pain and took fewer analgesics tablets than did the controls. In some patients the epoprostenol effect lasted for over 1 month.

U2 - 10.1016/S0140-6736(83)91625-2

DO - 10.1016/S0140-6736(83)91625-2

M3 - Article

SN - 0140-6736

VL - 321

SP - 315

EP - 317

JO - Lancet

JF - Lancet

IS - 8320

ER -

Epoprostenol (prostacyclin) and severe arterial disease: a double-blind trial

Abstract

Access to Document

Fingerprint

Cite this